SARS-CoV-2 Viral and Serological Testing When College Campuses Reopen: Some Practical ConsiderationsPolicy Analysis Published on 2020-07-272022-10-31 Journal: Disaster Medicine and Public Health Preparedness [Category] COVID-19, [키워드] acute respiratory syndrome approach close contact college communicable diseases coronavirus coronavirus disease COVID-19 Digital health Epidemics Implications infectious disease transmission Isolation nonpharmaceutical intervention pandemic Population Positive predictive value Protective quarantine resolved RT-PCR SARS-CoV-2 Serological testing seropositive social distancing social media spring Testing the United State university Vaccine [DOI] 10.1017/dmp.2020.266 PMC 바로가기 [Article Type] Policy Analysis
Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARS-CoV-2 infectionLetter Published on 2020-07-202022-10-31 Journal: Emerging Microbes & Infections [Category] COVID-19, MERS, SARS, [키워드] affected antibody antibody kinetics Contact ELISA Evidence Hospitalization IgA IgG IgG level individual infected patient Infection Mild moderate occurred pandemic physician positive positive IgG antibody Prevalence primary- and secondary-care physicians SARS-CoV-2 SARS-COV-2 infection Serological testing Symptom tested [DOI] 10.1080/22221751.2020.1793690 PMC 바로가기 [Article Type] Letter
Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreakOriginal Article Published on 2020-07-172023-06-16 Journal: European Journal of Clinical Microbiology & Infect [Category] MERS, SARS, [키워드] chemiluminescence immunoassay IgM and IgG SARS-CoV-2 Serological testing [DOI] 10.1007/s10096-020-03978-6 PMC 바로가기 [Article Type] Original Article
Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case reportCase Report Published on 2020-07-112022-10-28 Journal: BMC Infectious Diseases [Category] COVID-19, SARS, [키워드] anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody B cell Case report cause caused Chest computed tomography coronavirus disease COVID-19 detect determine discharge discharged discharged patient elevated excluded Extend isolation time ferritin hospital hospitals humoral immune response immunodeficiency Infection Isolation lesion Lymphocyte count measure Mutation New corona virus New coronavirus non-infectious occur Organizing pneumonia oropharyngeal swab Patient Pneumonia positive progression protective antibodies public health threat Pulmonary infection recovered patient recurrence Recurrent reduced responsible SARS-CoV-2 Sequencing Serological testing specific antibody Spread suffered the epidemic Total triggered TRNT1 virus World Health Organization [DOI] 10.1186/s12879-020-05231-z PMC 바로가기 [Article Type] Case Report
COVID-19 Serological Tests: How Well Do They Actually Perform?Review Published on 2020-07-042022-10-31 Journal: Diagnostics [Category] COVID-19, [키워드] absence Accuracy claimed conducted coronavirus disease COVID-19 COVID-19 incidence diagnostic test diagnostic tests discrepancy effective global pandemic highlight Immunity implementation increasingly independent initial Isolation Measures morbidity Mortality performance point-of-care public health quarantine rapid serological test SARS-CoV-2 serological serological diagnostic test Serological testing Spread the disease Vaccine Variability well Wuhan, China [DOI] 10.3390/diagnostics10070453 PMC 바로가기 [Article Type] Review
Efficacy of Serology Testing in Predicting Reinfection in Patients With SARS-CoV-2Concepts in Disaster Medicine Published on 2020-06-242022-10-31 Journal: Disaster Medicine and Public Health Preparedness [Category] COVID-19, [키워드] acute respiratory syndrome antibody Antibody testing approval ASC binding CD4 CD8 CDC center Control coronavirus COVID-19 develop disadvantage help IgG IgM and IgG immune response Immunity Immunoglobulin individuals infection rates inherent memory mutations Patient care polymerase chain prevention protocol question raise reached reduction in Reinfection robust SARS-CoV-2 serological test Serological testing serology test serology testing serum T-cell Testing the patient The United States utility Viral particles virus widespread [DOI] 10.1017/dmp.2020.216 PMC 바로가기 [Article Type] Concepts in Disaster Medicine
Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients SemiquantitativelyImmunoassays Published on 2020-06-242022-10-30 Journal: Journal of Clinical Microbiology [Category] COVID-19, MERS, [키워드] acute respiratory syndrome antibody automated average chemiluminescence CLIA clinical coronavirus CoV COVID-19 COVID-19 diagnosis Cutoff Diagnosis diagnostic diagnostics disease evaluated IgG immunoassays immunoserology Laboratory LIAISON measure Neutralization assay Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody neutralizing capacity offered pandemic performance plasma positive Predictive Protein provided ranged S1/S2 Safe SARS-CoV-2 selective sensitivity Serological testing serum specificity spike Test the SARS-CoV-2 therapeutic use to define Variation [DOI] 10.1128/JCM.01224-20 PMC 바로가기 [Article Type] Immunoassays
Identification of RT-PCR-Negative Asymptomatic COVID-19 Patients via Serological Testing혈청학적 검사를 통한 RT-PCR-음성 무증상 COVID-19 환자 식별Public Health Published on 2020-06-052022-09-12 Journal: Frontiers in Public Health [Category] MERS, SARS, 진단, [키워드] acute respiratory syndrome applied Asymptomatic Asymptomatic case asymptomatic individual asymptomatic patient Characteristics Clinical characteristics close contact coronavirus coronavirus disease COVID-19 identification individual Local negative RT-PCR nine no symptom nucleic acid Patient reverse transcription polymerase chain reaction RT-PCR test SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleic acid serological test Serological testing symptoms of COVID-19 Testing viral shedding virus [DOI] 10.3389/fpubh.2020.00267 PMC 바로가기 [Article Type] Public Health
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, IdahoImmunoassays Published on 2020-05-072022-10-30 Journal: Journal of Clinical Microbiology [Category] COVID-19, SARS, [키워드] Abbott Abbott SARS-CoV-2 IgG acute respiratory syndrome anti-SARS-CoV-2 IgG antibody Architect caused circulation Cohort collected coronavirus Coronavirus disease 2019 COVID COVID-19 Curve determine diagnostic evaluated False positive Idaho individual infections morbidity and mortality Patient PCR positivity performance populations positive reached Respiratory illness reverse transcription-PCR RT-PCR SARS SARS-CoV-2 SARS-CoV-2 IgG sensitivity Serological testing serology Seroprevalence serum specificity specimen symptom onset tested the United State threshold United States virus [DOI] 10.1128/JCM.00941-20 PMC 바로가기 [Article Type] Immunoassays
Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patientsLetter Published on 2020-05-022022-10-31 Journal: Emerging Microbes & Infections [Category] COVID-19, MERS, SARS, [키워드] 2019 novel coronavirus acute respiratory syndrome antibody Antibody Response Antibody responses assist Asymptomatic carrier Asymptomatic carriers Clinical diagnosis Clinical symptoms collected complementary conducted Consensus coronavirus COVID-19 COVID-19 patient COVID-19 patients disease severity follow-up period groups Hospitalization Humoral response individual infected with SARS-CoV-2 information Jiangsu longitudinal pattern mitigate non-severe cases nucleic acid nucleic acid test observation period pandemic Prognosis reported responses SARS-CoV-2 sera Seroconversion seroconverted Serological testing serology testing severe cases severe COVID-19 patient swab sample symptomatic Vaccine design Viral antigen viral nucleic acid viral replication Viral RNA virus [DOI] 10.1080/22221751.2020.1756699 PMC 바로가기 [Article Type] Letter